Correlation Between Eliem Therapeutics and United Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and United Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and United Therapeutics.
Diversification Opportunities for Eliem Therapeutics and United Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eliem and United is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and United Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and United Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the United Therapeutics. In addition to that, Eliem Therapeutics is 2.24 times more volatile than United Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. United Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 36,140 in United Therapeutics on August 31, 2024 and sell it today you would earn a total of 909.00 from holding United Therapeutics or generate 2.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 91.3% |
| Values | Daily Returns |
Eliem Therapeutics vs. United Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| United Therapeutics |
Eliem Therapeutics and United Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and United Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| United Therapeutics vs. Incyte | United Therapeutics vs. Alnylam Pharmaceuticals | United Therapeutics vs. Ultragenyx | United Therapeutics vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |